Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19

12Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Introduction: Developing prognostic markers can be useful for clinical decision-making. Peripheral blood (PB) examination is simple and basic that can be performed in any facility. We aimed to investigate whether PB examination can predict prognosis in coronavirus disease (COVID-19). Methods: Complete blood count (CBC) and PB cell morphology were examined in 38 healthy controls (HCs) and 40 patients with COVID-19. Patients with COVID-19, including 26 mild and 14 severe cases, were hospitalized in Juntendo University Hospital (Tokyo, Japan) between April 1 and August 6, 2020. PB examinations were performed using Sysmex XN-3000 automated hematology analyzer and Sysmex DI-60 employing the convolutional neural network-based automatic image-recognition system. Results: Compared with mild cases, severe cases showed a significantly higher incidence of anemia, lymphopenia, and leukocytosis (P

Cite

CITATION STYLE

APA

Horiuchi, Y., Hayashi, F., Iwasaki, Y., Matsuzaki, A., Nishibe, K., Kaniyu, K., … Tabe, Y. (2021). Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID-19. International Journal of Laboratory Hematology, 43(6), 1309–1318. https://doi.org/10.1111/ijlh.13696

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free